New infectious disease center to build local expertise in
Vietnam
25 September 2002 10:00 GMT
by Bea Perks
The opening of a national center for infectious disease
research in Ho Chi Minh City, Vietnam, signals a turning point in
the understanding of some of the country's biggest killers, say
researchers. "We hope that as the laboratories become established
we will see a big impact on our basic understanding of the immune
pathogenesis of dengue, malaria, typhoid and infections of the CNS
[central nervous system]," said the director of the new Department
of Laboratory Sciences, Jeremy Farrar.
The new venture has been undertaken thanks to a funding
collaboration between the Vietnamese government and the UK charity
the Wellcome Trust. The government paid for the construction of a
$1 million building to house the research, while the Wellcome
Trust provided $1.5 million for laboratory equipment. In addition,
the Trust has committed to fund research at the Department until
at least 2005.
The vice-director of the Hospital for Tropical Diseases, on
whose grounds the new Department is siutated, warmly welcomed the
new Department, which was officially opened last Friday. "[It]
will have a great impact, not only on our research but also on the
quality of patient care by improving the quality of diagnosis and
treatment," said Tran Tinh Hien.
One of Hien's concerns, however, is the need for "home-grown"
research in Viet Nam.
"It means nothing if we cannot be able to form a class of
Vietnamese researchers after ten years!" he said. Tien, who is a
consultant for the World Health Organization (WHO) on the clinical
management of malaria, and whose interests lie in malaria, typhoid
fever, and dengue, has worked in Viet Nam all his life.
Farrar says that there will be no more than 15 expatriate staff
working at the new Department, which will house some 150 staff
members. Research there will both continue and advance ongoing
programs at the Hospital, which has had a collaborative research
program with the Wellcome Trust since 1991. Work will still
revolve around five core areas, says Farrar: malaria, dengue,
infections of the CNS, typhoid and tetanus. Clinical work will be
central, he says, but research will now extend into understanding
mechanisms of pathogenesis in greater detail.
According to a WHO report, more than a third of the Vietnamese
population, 26 million people, live in malaria endemic areas.
Deaths, however, fell by 97% between 1992-7 thanks largely to a
Chinese herbal medicine, called qinghaosu, that was studied in
Viet Nam in 1991 in a collaborative project with the Wellcome
Trust. The WHO also reports that drug resistant strains of typhoid
and TB pathogens are prevalent in the country - 90% of strains of
Salmonella typhi (the bacterium responsible for typhoid
fever), for example, are reported to be resistant to most
available drugs in the country.
"Malaria, typhoid and TB are the three areas where the biggest
impact is likely to come," said Farrar. "The Hospital has had a
significant influence on the National and WHO [World Health
Organization] guidelines on how to treat malaria and typhoid," he
went on, adding that current research may change the way TB
meningitis is treated.
The challenge now, he says, is to repay the investment made by
the Vietnamese government, the Wellcome Trust, and long-standing
support from the Ho Chi Minh City Health Service, by making an
impact on diseases important to Viet Nam. "It's a challenge!" he
admitted.
Picture caption and credit:
Vietnam with typhoid background. Typhoid image courtesy of
CDC/Armed Forces Institute of Pathology, Charles N. Farmer.

|
Send us your
comments for
publication.
|
| Sign up for BioMedNet News weekly
email alerts. |